Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.38 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.38 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.38 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.38 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.38 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.38 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.38 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.38 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.38 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.38 |
| ▸ | PSMB4 | P28070 | 1/20 | 0.38 |
| ▸ | PSMB6 | P28072 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.38 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.38 |
| ▸ | PSMB3 | P49720 | 1/20 | 0.38 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.38 |
| ▸ | PSMA6 | P60900 | 1/20 | 0.38 |
| ▸ | PSMA8 | Q8TAA3 | 1/20 | 0.38 |
| ▸ | PSMB7 | Q99436 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15552073 | 0.81 | PRKCA (0.40) | PRKCAPSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL2240463 | 0.78 | PRKCA (0.37) | PRKCAPSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL234408 | 0.78 | PRKCA (0.37) | PRKCAPSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL10385584 | 0.78 | PRKCA (0.41) | PRKCAPSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL25290831 | 0.75 | PRKCA (0.37) | PRKCAPSMB11PSMA7PSMB1PSMA1 | |
| SCHEMBL3245958 | 0.74 | PRKCA (0.36) | PRKCAPOLBFASNALOX5CYP1A2 | |
| SCHEMBL7604302 | 0.74 | PRKCA (0.36) | PRKCAPOLBCYP1A2 | |
| SCHEMBL9240962 | 0.72 | MEN1 (0.38) | PRKCACYP1A2 | |
| SCHEMBL28023532 | 0.71 | ALOX5 (0.41) | ALOX5PTPN1 | |
| SCHEMBL26695374 | 0.70 | ALOX5 (0.43) | ALOX5PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 842 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| WO-2020015880-A1 | BI-PHASE DEODORIZING COSMETIC COMPOSITION | BEIERSDORF AG (DE) | 2020-01-23 | — | — | WO | claimed |
| EP-3423028-A1 | METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY | Symrise AG (DE) | 2019-01-09 | — | — | EP | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | SYMRISE AG (DE) | 2026-02-17 | — | — | US | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-0842250-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-20 | — | — | EP | disclosed |
| US-5747443-A | BIODEGRADABLE QUATERNARY AMMONIUM COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-05 | — | — | US | disclosed |
| WO-1998017756-A1 | CONCENTRATED FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1998017750-A1 | CONCENTRATED, FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1998-04-30 | — | — | WO | disclosed |
| WO-1997034972-A1 | FABRIC SOFTENING COMPOUND/COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997016516-A1 | STABLE HIGH PERFUME, LOW ACTIVE FABRIC SOFTENER COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-05-09 | — | — | WO | disclosed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | PRKCA 3335/4885PSMB11 2205/4885PSMA7 2152/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | PRKCA 4055/4885PSMB11 1318/4885PSMA7 662/4885 |
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | FAAH2, ADCY10, OR10J3 | PRKCA 1144/4885PSMB11 1617/4885PSMA7 1096/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | PRKCA 4723/4885PSMB11 826/4885PSMA7 144/4885 |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | PRKCA 4150/4885PSMB11 1583/4885PSMA7 623/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | PRKCA 4375/4885PSMB11 2228/4885PSMA7 4135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.